Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis

Madoka Seki1, Kiyoko Tanaka1, Rei Kikuchi-Yanoshita1, Motoko Konishi1, Hiroyuki Fukunari2, Takeo Iwama2, and Michiko Miyaki1

1 Department of Biochemsitry, The Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo, 113 Japan

2 Department of Surgery, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo, 113 Japan

Received September 1, 1991 / Revised December 5, 1991

Summary. Endocrine neoplasms have been reported oc- casionally in patients with familial adenomatous poly- posis (FAP). An adrenocorotical carcinoma was studied in a patient with a family history of FAP. Loss of hetero- zygosity (LOH) in the region close to the adenomatous polyposis coli (APC) gene was detected in this carcinoma, and evidence was obtained that there was a loss of the normal allele of the APC gene. This is the first demon- stration of LOH at the APC locus in adrenocortical tu- mors. The present results and our previous data on LOH in a recurring desmoid tumor suggest that the heterozyg- ous mutant/wild-type condition of the APC gene may give rise to benign tumors, and that functional loss of this gene leads to development of tumors not only in the colon but also in other various parts of the body in FAP patients.

Introduction

Familial adenomatous polyposis (FAP) is an autosomal dominant trait that is determined by the heterozygous mutant APC gene on chromosome 5q21-22 (Herrera et al. 1986; Bodmer et al. 1987; Leppert et al. 1987) and characterized by numerous benign colorectal adenomas and a high incidence of colorectal carcinomas. FAP is not solely colonic disease, and there have been reports of other benign and malignant tumors occurring in pa- tients, including gastric and duodenal polyps and car- cinomas, osteomas, desmoid tumors and endocrine ade- nomas and carcinomas (Jagelman 1987). It has also been reported that endocrine adenoma is significantly more frequent in FAP than in other cancer patients (Schneider et al. 1983; Painter et al. 1985). These data suggest that the APC gene may play an important role in growth dis- order and tumroigenesis in various parts of the body in FAP patients.

We have previously observed the loss of the normal allele of the APC gene not only in many colonic tumors from FAP patients (Miyaki et al. 1990) but also in a de- smoid tumor from a patient (Okamoto et al. 1990). To examine the pleiotropic effect of inactivation of the APC gene, we performed restriction fragment length poly- morphism (RFLP) analysis on an adrenocortical carcino- ma formed in an FAP patient and detected loss of het- erozygosity (LOH) in the APC region.

Materials and methods

Tumor and normal tissues were obtained from FAP patients treated at Tokyo Medical and Dental University. A tumor sample from PLK91 (63-year-old woman) was diagnosed histopathologically as adrenocortical carcinoma. DNA extraction, Southern blotting and hybridization were performed as described previously (Miyaki et al. 1990). The following RFLP probes were used: L-myc (1p32), YNZ2 (1p), D3S2 (3p14-21), D5S6 (5q13), D5S37 (5q21-22), D5S71 (5q21-22), D5S81 (5q21-22), H-ras-I (11p15.5), INS (11p15), D11S12 (11p15.5), INT2 (11q13), D17S30 (17p13.3), D18S5 (18q21.3-ter) and IGLC (22q11.1-11.2).

Results and discussion

An adrenocortical carcinoma was found in an FAP pa- tient (PLK91). To elucidate the contribution of the APC gene in this tumor we analyzed LOH in the region close to the APC gene. Two probes, D5S81 (YN5.48) and D5S37 (Pi227) which have been reported to be closely linked to APC (Nakamura et al. 1988; Stewart et al. 1987; Meera Khan et al. 1988) detected the LOH in this tumor as indicated in Fig. 1. These probes detected fre- quent LOH in colorectal tumors from FAP patients (Mi- yaki et al. 1990) and also loss in a desmoid tumor (Oka- moto et al. 1990). To examine which allele of the pair at the APC locus was lost in the tumor, we performed RFLP analysis on normal tissues in the patient’s brother, daugh-

Figs. 1. Loss of heterozygosity as determined by Southern blotting and hybridization with probes mapping close to the APC gene in adrenocortical carcinoma from PLK91. N, Normal; Ca, carcinoma

D5S81 / Mspl

D5S37 /Pst |

N Ca

N Ca

a1

a1

a3

a2

PLK91

PLK91

ter and grandchild with a history of FAP (Fig. 2). Nor- mal tissue from PLK91 was heterozygous in D5S81 and D5S37, and allele 1 of D5S81 and allele 1 of D5S37 were absent in her adrenocortical carcinoma (Ca). Allele 3 of D5S81 and allele 2 of D5S37 were retained. These alleles were inherited by her affected brother (D16), affected daughter (PLK61) and affected grandchild (D45), and the mutant allele of the APC gene was assumed to be re- tained with these alleles in this tumor. This result pro- vided evidence for loss of the normal allele of the APC gene, which leads to loss of the suppressing function of the APC gene in the adrenocortical carcinoma.

LOH on chromosomes 1, 3, 11, 17, 18 and 22 was also examined. However, no LOH was detected in H-ras-1, D11S12 and INS on chromosome 11p which have been reported to be lacking in adrenocortical carcinomas from patients with Beckwith-Wiedemann (BW) syndrome and familial adrenocortical carcinoma (ADCC) (Henry et al. 1989) and in malignant adrenocortical carcinomas from sporadic cases (Yano et al. 1989). The genes for the he- reditary diseases, BW and ADCC, are located in this re- gion. The reason for the absence of LOH on chromosome

11p in the same tumor in this FAP patient may be inter- preted as follows: (1) the probes used in the present study could not detect LOH because they are located far from the BW or ADCC gene; (2) both alleles of BW or ADCC were inactivated by point mutations; or (3) in the case of FAP patients, inactivation of the APC gene contributes to development of adrenocortical tumors instead of inac- tivation of the gene on chromosome 11p.

It has been suggested from our previous results that the heterozygous mutant/wild-type condition of the APC gene may bring about the formation of benign colorectal adenomas with mild or moderate dysplasia, and loss of the normal allele of the APC gene develops adenomas to a condition of severe dysplasia. The severe adenomas may then convert and progress into malignant carcinomas accompanied by LOH in tumor suppressor genes on chro- mosomes 17p, 18q, 22q, etc. Similar inactivation of the APC gene has been suggested to contribute to the de- velopment of extracolonic tumors in FAP patients by the fact that LOH of the APC region was detected in a large recurring desmoid tumor, but has not been detected in small desmoid tumors. The LOH in a malignant adreno- cortical tumor described in this report may support the idea that half loss of the tumor suppressor activity of the APC gene is the cause of extracolonic benign tumors in FAP patients, and that full loss causes development of the tumors to an advanced stage. Further study with a large number of tumors is needed to confirm this hypo- thesis, and more detailed analysis of the genetic changes of the APC gene in tumors is also required, since the structure of the APC gene has recently been clarified (Groden et al. 1991; Kinzler et al. 1991).

Acknowledgements. This work was supported in part by Grants-in- Aid for Cancer Research from the Ministry of Education, Science and Culture of Japan. We are grateful to Dr. Y. Nakamura, Dr. G. D. Stewart and other scientists for providing YN5.48, Pi227 and other probes. Several probes were provided through the Japanese Cancer Research Resources Bank.

Fig. 2. Inheritance of the mutant allele of APC gene on chromosome 5q in normal tissue (N) of the familial adenomatous polyposis (FAP) family members (PLK91, D16, PLK61 and D45), and retention of the mutant allele of APC in the adrenocortical carcinoma (Ca) of PLK91. The presumptive location of the normal APC gene is marked +, and the mutant APC gene, *, FAP patients, O, unaffected individu- als

D16

N

D5S37 2

2

D5S71 2

2

PLK91

N

Ca

APC

+

*

D5S37

1

2

2

D5S81 1

3

D5S71

2

2

2

APC

+

*

*

D5S81

1

3

3

PLK61

N

D5S37

1

2

D5S71

2

2

APC

+ *

D5S81

3

3

D45

N

D5S37

2

2

D5S71 2

2

APC + *

D5S81 2 3

References

Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P, Sheer D, Solomon E, Spurr NK (1987) Localization of the gene for fa- milial adenomatous polyposis in chromosome 5. Nature 328: 614-616

Groden J, Thliveris A, Saowitz W, Carlson M, Gelbert L, Al- bertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sar- geant L, Krapcho K, Wolff E, Randall B, Hughes JP, Warring- ton J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M, White R (1991) Identification and char- acterization of the familial adenomatous polyposis coli gene. Cell 66:589-613

Henry I, Grandjouan S, Couillin P, Barichard F, Huerre-Jean- pierre C, Glaser T, Philip T, Lenoir G, Chaussain JL, Junien C (1989) Tumor-specific loss of 11p15.5 alleles in del 11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci USA 86:3247-3251

Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg A (1986) Brief clinical report: Gardner syndrome in a man with a inters- titial deletion of 5q. Am J Med Genet 25: 473-476

Jagelman DG (1987) Extracolonic manifestations of familial poly- posi coli. Cancer Genet Cytogenet 27:319-325

Kinzler KW, Nibert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, Mckechnie D, Fin- niear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y (1991) Identification of FAP locus genes from chromsome 5q21. Science 253:661-669

Leppert M, Dobbs M, Scambler P, O’Connel P, Nakamura Y, Stauffer D, Woodward S, Burt R, Hughes J, Gardner E, Lath- rop M, Wasmuth J, Lalonel JM, White R (1987) The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238: 1411-1413

Meera Khan P, Tops CMJ, Broek M (1988) Close linkage of a highly polymorphic marker (D5S37) to familial adenomatous polyposis (FAP) and confirmation of FAP localization on chro- mosome 5q21-22. Hum Genet 79: 183-185

Miyaki M, Seki M, Okamoto M, Yamanaka A, Maeda Y, Tanaka K, Kikuchi R, Iwama T, Ikeuchi T, Tonomura A, Nakamura Y, White R, Miki Y, Utsunomiya J, Koike M (1990) Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res 50: 7166-7173

Nakamura Y, Lathrop M, Leppert M, Dobbs M, Wasmuth J, Wolff E, Carlson M, Fujimoto E, Krapcho K, Sears T, Wood- ward S, Hughes J, Burt R, Gardner E, Lalouel JM, White R (1988) Localization of the genetic defect in familial adenomat- ous polyposis within a small region of chromosome 5. Am J Hum Genet 43:638-644

Okamoto M, Sato C, Kohno Y, Mori T, Tonomura A, Miki Y, Ut- sunomiya J, Nakamura Y, White R, Miyaki M (1990) Molecu- lar nature of chromosome 5q loss in colorectal tumors and des- moids from patients with familial adenomatous polyposis. Hum Genet 85:595-599

Painter TA, Jegelman DG (1985) Adrenal adenomas and adrenal carcinomas in association with hereditary adenomatosis of the colon and rectum. Cancer 55:2001-2004

Schneider NR, Cubilla AL, Chaganti RSK (1983) Association of endocrine neoplasis with multiple polyposis of the colon. Can- cer 51:1171-1175

Stewart GD, Bruns GAP, Wasmuth JJ, Kurnit DM (1987) An anonymous DNA segment (Pi277) Maps to the long arm of human chromosome 5 and identifies a BstXI polymorphism (D5S26). Nucleic Acids Res 15:3939

Yano T, Linehan M, Anglard P. Lerman MI, Daniel LN, Stein CA, Robertson CN, La Rocca R, Zbar B (1989) Genetic changes in human adrenocortical carcinomas. J Natl Cancer Inst 81:518- 523